Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Renna

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Inflammatory Bowel Diseases|December 28, 2018
Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-AnalysisFabio Salvatore Macaluso, Marcello Maida, Marco Ventimiglia, et al.
Scandinavian Journal of Gastroenterology|September 7, 2019
Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohortFabio Salvatore Macaluso, Chiara Sapienza, Marco Ventimiglia, et al.
The Journal of Infection|March 7, 2017
Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel diseaseGiovanni Mazzola, Fabio Salvatore Macaluso, Lucia Adamoli, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational studyFilippo Mocciaro, Sara Renna, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|August 13, 2011
Adalimumab in steroid-dependent Crohn's disease patients: prognostic factors for clinical benefitAmbrogio Orlando, Sara Renna, Filippo Mocciaro, et al.
Immunotherapy|November 29, 2023
Role of ustekinumab in treatment of ulcerative colitis: a narrative reviewMauro Grova, Alessandro Vitello, Mariella Mannino, et al.
Acta Gastro-Enterologica Belgica|March 6, 2014
Is really megacolon a contraindication to infliximab in Crohn's disease?Emanuele Sinagra, Ambrogio Orlando, Sara Renna, et al.
European Journal of Gastroenterology & Hepatology|May 29, 2009
Is splenectomy a treatment option for aseptic abscesses in patients with Crohn's disease?Sara Renna, Filippo Mocciaro, Giovanni Perricone, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2022
Effectiveness and safety of an on-demand ferric carboxymaltose infusion strategy in patients with inflammatory bowel disease: a real world experienceMauro Grova, Federica Crispino, Marcello Maida, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 16, 2023
Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologicsMauro Grova, Federica Crispino, Marcello Maida, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Inflammatory Bowel Diseases|December 28, 2018
Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-AnalysisFabio Salvatore Macaluso, Marcello Maida, Marco Ventimiglia, et al.
Scandinavian Journal of Gastroenterology|September 7, 2019
Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohortFabio Salvatore Macaluso, Chiara Sapienza, Marco Ventimiglia, et al.
The Journal of Infection|March 7, 2017
Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel diseaseGiovanni Mazzola, Fabio Salvatore Macaluso, Lucia Adamoli, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational studyFilippo Mocciaro, Sara Renna, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|August 13, 2011
Adalimumab in steroid-dependent Crohn's disease patients: prognostic factors for clinical benefitAmbrogio Orlando, Sara Renna, Filippo Mocciaro, et al.
Immunotherapy|November 29, 2023
Role of ustekinumab in treatment of ulcerative colitis: a narrative reviewMauro Grova, Alessandro Vitello, Mariella Mannino, et al.
Acta Gastro-Enterologica Belgica|March 6, 2014
Is really megacolon a contraindication to infliximab in Crohn's disease?Emanuele Sinagra, Ambrogio Orlando, Sara Renna, et al.
European Journal of Gastroenterology & Hepatology|May 29, 2009
Is splenectomy a treatment option for aseptic abscesses in patients with Crohn's disease?Sara Renna, Filippo Mocciaro, Giovanni Perricone, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2022
Effectiveness and safety of an on-demand ferric carboxymaltose infusion strategy in patients with inflammatory bowel disease: a real world experienceMauro Grova, Federica Crispino, Marcello Maida, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 16, 2023
Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologicsMauro Grova, Federica Crispino, Marcello Maida, et al.
Pageof 7